LONDON, June 14, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics (AUTL) plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces three ...
The press release below was prepared by the American Association for Cancer Research. View the original here. Next-generation sequencing for minimal residual disease was highly sensitive and more ...
Cytidine deamination that is guided by clustered regularly interspaced short palindromic repeats (CRISPR) can mediate a highly precise conversion of one nucleotide into another — specifically, ...
Underuse of Breast Cancer Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust Speed of blast clearance is an indicator of outcome in childhood acute lymphoblastic leukemia (ALL).
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Before HCT, 88 patients met morphologic criteria for complete remission (CR), ...
If you work in cell biology or immunology, chances are that you're familiar with flow cytometry. This technique measures and analyzes biological cells by suspending them in a stream of fluid and ...
Over the past decade, flow cytometry has undergone transformative advancements, notably with the adoption of spectral flow cytometry and the emergence of next-generation imaging cytometers. These ...
“Corticosteroids are well established as a highly effective component of treatment to induce remission in ALL; thus, processes that increase endogenous corticosteroid production may be responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback